2B57 Kaposi sarcoma, primary site
International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2026-01
A malignant neoplasm characterised by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).
sections/codes in this section ()
- Kaposi sarcoma of lung (2B57.0)
- Kaposi sarcoma of skin (2B57.1)
- Kaposi sarcoma of gastrointestinal sites (2B57.2)
- Kaposi sarcoma of other specified primary sites (2B57.Y)
- Kaposi sarcoma of unspecified primary site (2B57.Z)
postcoordination
Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com